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The hippocampal formation is composed of separate anatomical regions interconnected to form a circuit, and investi-
gating abnormal hippocampal function is most revealing at the level of these regions. Until recently, regional analysis of
the hippocampal formation could be performed only in animals or in human postmortem tissue. Here, we report a
method using functional magnetic resonance imaging that evaluates the hippocampal regions in vivo, and we use this
method to study elderly with normal memory, with isolated memory decline, and with probable Alzheimer’s disease
(AD). Although age-related memory decline occurs commonly, the cause of this decline remains unknown, with dis-
agreement as to whether this decline represents one or more etiologies. Analysis revealed two distinct patterns of regional
dysfunction among elderly with isolated memory decline—one pattern similar to that found in elders with AD, involving
all hippocampal regions, and a second pattern with dysfunction restricted to only one hippocampal region, the subicu-
lum. These results offer direct evidence of hippocampal dysfunction associated with memory decline in the elderly, and
implicate both predementia AD and non-AD processes as possible underlying causes.
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Amnestic patients with discrete lesions,1,2 lesion studies
in animals,3 and recent functional neuroimaging stud-
ies4,5 have established a role for the hippocampal for-
mation in consolidating new declarative memories. In-
creased interest in the hippocampus has led to a more
detailed understanding of its microanatomy and phys-
iology. In its transverse axis, the hippocampal forma-
tion is made up of different regions that are intercon-
nected to form a complex circuit.6 These regions
include the entorhinal cortex that serves as the main
gateway into the hippocampal circuit, the “hippocam-
pus proper” composed of the dentate gyrus and cornus
ammonis (CA) subfields, and the subiculum. The
physiological properties of hippocampal neurons have
also been investigated, and these efforts have revealed
mechanisms of cellular plasticity, including long-term
potentiation.7 Synapses in different hippocampal re-
gions use varying forms of long-term potentiation,8
and some of these may underlie the mnemonic func-
tion of the hippocampus.
Thus, the hippocampal formation is not a simple
unitary structure. Rather, it is anatomically complex
and physiologically diverse. When investigating mech-
anisms of memory dysfunction, evaluating the hip-
pocampus globally may be incompatible with its level
of complexity. The advantages of a regional approach
to hippocampal function have been exploited in animal
studies9 and, in a more limited fashion, in human
postmortem studies.10–12 Until recently, however, in
vivo methods did not possess adequate spatial resolu-
tion to perform regional analysis of the hippocampal
formation. Functional magnetic resonance imaging
(fMRI), a relatively new neuroimaging technique,13 has
enhanced spatial resolution that is within the dimen-
sions of the hippocampal subregions. Recent struc-
tural14 and functional MRI15 studies have successfully
demonstrated its ability to selectively evaluate the dif-
ferent regions. In the current study we use an fMRI
protocol that was specifically developed for hippocam-
pal regional analysis to investigate age-related memory
decline.
Memory decline with age is common, with some re-
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ports suggesting a prevalence of .40% among individ-
uals of .60 years.16 One component of this decline
affects declarative memory function17,18 and it is
thought to localize to the hippocampal formation.19
Because of a bimodal distribution of memory scores in
aging animals and humans,20 where many older indi-
viduals perform as well as younger controls, memory
decline may not be an inevitable consequence of aging.
What, then, are the possible causes of age-related mem-
ory decline? The first brain structure to be targeted by
Alzheimer’s disease (AD) is the hippocampal forma-
tion,21 and correspondingly, prospective studies have
found that memory deficits are the first signs of AD.22
Recent studies have shown that entorhinal cell loss oc-
curs in the predementia stage of the disease.10 It is
likely, therefore, that early AD is one contributing
cause of age-related memory decline. Although the as-
sociation between age-related memory decline and AD
awaits further confirmation, a more contentious issue is
whether AD can explain all cases of elderly patients
with memory decline. This is particularly important, as
there are age-dependent changes in some physiological
processes, such as hormone levels and cerebrovascular
supply, that can affect the hippocampal formation and
result in memory impairment.23–26 Although these
processes may interact with AD, as modifiers or even
triggers of disease, recent postmortem studies have doc-
umented age-related cell loss in the hippocampal for-
mation among brains free of AD pathology.11,12 A
limitation of these studies is that antemortem evalua-
tion of memory function were not performed. Aside
from structural lesions, non-AD processes might also
cause functional damage to hippocampal neurons. Ex-
tensive animal research has documented age-dependent
changes in the physiological properties of hippocampal
neurons,9,19 and some may explain non-AD memory
decline found pervasively in aging animals.
Although both early AD and non-AD processes in-
volve the hippocampal formation, they appear to target
different hippocampal subregions. The first hippocam-
pal region to be targeted by AD is the entorhinal cor-
tex, as evidenced by changes in synaptic integrity,26
reduction in cell density,10 and the formation of neu-
rofibrillary tangles.21 In contrast, both postmortem
studies11,12 and electrophysiological studies in aging
animals9,19 have shown that non-AD processes spare
the entorhinal cortex, with selective targeting of other
hippocampal regions. Because these regions form a cir-
cuit, any lesion can interrupt this circuit and may sim-
ilarly impair the global function of the hippocampus,
as measured by memory tests27 or some imaging tech-
niques. Dissociating early AD from non-AD causes of
memory decline, therefore, may necessitate a regional
analysis of the hippocampal formation. Because lesions
to hippocampal regions can disrupt the physiological
function of hippocampal neurons, and not necessarily
result in cell loss, fMRI analysis may detect changes
that could be missed by volumetric MRI analysis.28
Recent functional imaging techniques, such as positron
emission tomography and single-photon emission com-
puted tomography, have detected whole brain activa-
tion patterns that discriminate individuals who are at
risk for developing AD dementia,29–31 and some stud-
ies have found a decrease in global hippocampal func-
tion associated with memory impairment.32 To date,
however, these methods do not possess the spatial res-
olution to selectively assess different regions within the
hippocampal formation and may therefore have diffi-
culty in dissociating processes that result in memory
decline by targeting different regions.
Subjects and Methods
Subjects
The following three groups of individuals more than 65
years of age participated in the study: (1) 4 subjects with
normal memory, (2) 12 subjects with isolated memory de-
cline, and (3) 4 subjects with AD. Subjects from the first two
groups were drawn from a single community and were eval-
uated prospectively with annual medical, neurological, and
neuropsychological examinations (the details of this workup
are described elsewhere33). All subjects were presented in a
consensus conference composed of neurologists, psychiatrists,
and neuropsychologists, and were excluded if at any time
point they fulfilled the Diagnostic and Statistical Manual of
Mental Disorders34 (DSM-IV) criteria for dementia, or if they
were diagnosed with stroke, Parkinson’s disease, or depres-
sion. Subjects were also excluded if they were diagnosed with
“questionable dementia,” a category applied if neuropsycho-
logical test performance was below cutoff scores established
for this community,35 but were not extensive enough to ful-
fill dementia criteria. A slope of memory performance over
time was calculated for each subject by performing a linear
regression of the total recall score of the Selective Reminding
Test,36 a measure of declarative memory. Subjects were as-
signed to the memory decline group if their memory perfor-
mance worsened with time; and they were assigned to the
normal memory group if their memory did not decline over
time. Subjects for the AD group were selected from a clinical
setting. They all fulfilled DSM-IV34 criteria for dementia,
and NINCDS-ADRDA37 (National Institute of Neurologi-
cal and Communicative Disorders and Stroke–Alzheimer’s
Disease and Related Disorders Association) criteria were used
for the diagnosis of probable AD. Only subjects with mild
dementia (clinical rating scale38 5 1) were selected, based on
preliminary studies showing that individuals with more
profound dementia could not perform the cognitive activa-
tion task.
Task Design
Stimuli were black-and-white photographs taken from a high
school yearbook. All faces were stored digitally in a Macin-
tosh laptop computer and were organized with the Psyscope
(Pittsburgh, PA) software program. Faces were projected
onto a back-projection screen located at the foot of the mag-
netic resonance imaging (MRI) bed via an LCD (light-
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emitting diode) projector located outside the scanner room.
Subjects viewed the screen via a prism system located in the
head coil. All faces were presented one at a time, 4.4 seconds
per stimulus, with an interstimulus interval of 0.6 seconds.
Responses were recorded with a button box designed for use
in the MRI suite.
To accommodate the needs of the subjects, some with
memory decline or dementia, the task was kept simple and
relatively brief. The task lasted 4 minutes during which an
activation phase, made up of 12 faces, alternated with a base-
line phase consisting of a fixation point. Task design was as
follows: Activation phases occurred during the first and third
minutes, and baseline phases during the second and fourth
minutes. Thus, in two activation phases a total of 24 differ-
ent faces were used, with an equal division of sex. Subjects
were instructed to push one button if a face was male and
the other button if a face was female. All subjects, including
the AD patients, were able to discriminate sex with 100%
accuracy. Left or right button responses that corresponded to
sex were pseudorandomized across different subjects within
each experimental group. Subjects were instructed to remem-
ber the faces for future testing.
Scanning Methods
Scanning was done on a 1.5-T magnetic resonance scanner
retrofitted for echo planar imaging. A gradient echo sequence
(echo time [TE] 5 60 msec; repetition time [TR] 5 2.5
seconds; flip angle 5 30°) and a standard quadrature head
coil were used to acquire T2*-weighted images with an in-
plane resolution of 2.3 3 2.3 mm (64 3 64 matrix; 15-cm2
field of view). High-resolution “fast multiplanar inversion re-
covery” images were also acquired, using the same spatial co-
ordinates (TE 5 43 msec; TR 5 6500 msec; inversion
time 5 200 msec; 512 3 512 matrix; 15-cm2 field of view).
Six 5-mm slices were selected that were oriented along the
long axis of the hippocampal formation. The choice of the
most anterior image was based on identification of the alveus
and on the image where the temporal horn resides both lat-
erally and superior to the hippocampus proper.39 Thus, the
most posterior slice was approximately 35 mm caudal to the
amygdala, ensuring incorporation of the entorhinal cortex.40
Image analysis was performed on a Silicon Graphics In-
digo II workstation, using image display and analysis soft-
ware packages (MEDx Sensor Systems, Boulder, CO; IDL
Research Systems, Sterling, VA). The AIR41 program was ap-
plied to correct for head motion and to coregister the vol-
umes. Although the short acquisition time of the runs en-
hanced the goodness-of-fit of the algorithm head motion is
particularly important in this study, as small brain regions
were under investigation. Studies were rejected if a shift of
.1 mm over the scanning time period was detected in any
direction after coregistration. Spatial filtering was not used in
postacquisition processing, because it effectively reduces both
spatial resolution and spatial fidelity.
Data Analysis
The structural MRI scanning images, which were developed
to highlight the internal architecture of the hippocampus
(Fig 1), were used to localize three hippocampal regions for
each subject—the entorhinal cortex, the hippocampus proper
composed of the dentate gyrus and CA subfields, and the
subiculum. Fixed anatomical criteria,40–42 demonstrated by
others to successfully localize hippocampal regions,14,15 were
used to define these regions by an investigator blinded to
experimental grouping. To preserve statistical power, analysis
was performed only on pixels within these regions of interest.
Pixel-by-pixel t tests were performed for each subject,
comparing the average signal intensity acquired during the
activation phases versus the average signal intensity acquired
during baseline. Because the goal of this study was to maxi-
mally drive the hippocampal formation, the activation and
the baseline conditions were purposefully unmatched, since
both visual complexity and a motor output contribute to ac-
tivity in hippocampal neurons.43 To account for multiple t
testing, we adopted a method developed for multiple single-
unit recordings of the hippocampus44 to determine an a
level that would indicate significant activation. In this
method, an a level is chosen, and based on the number of
data points sampled, the number of significant data points
expected by chance is determined. A x2 analysis is then per-
formed, comparing the number of observed significant data
points with the number expected by chance. In a preliminary
series of studies with young and older subjects with normal
memory, we found significant hippocampal activation with
Fig 1. Transverse slices through the hippocampal formation. The high-resolution magnetic resonance imaging (MRI) acquisition
parameters were specifically developed to highlight the internal architecture of the hippocampal formation. (Right) Example of an
MRI slice from 1 subject. (Left) Histological slice of a different hippocampus in approximately the same orientation.
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an a of 0.05. We used this a level for all analyses. To per-
form group data analysis, an investigator blinded to experi-
mental condition counted the number of pixels whose he-
modynamic response significantly increased in association
with facial processing. Atrophy was not corrected for because
we were interested in activation differences that may result
either from structural changes (atrophy and cell loss) or from
physiological changes in synaptic efficacy. The number of
significant pixels for each hippocampal region was aggregated
for each experimental group. In the first experiment, these
values were used as the dependent variables in a one-factor
multivariate analysis of variance comparing activation be-
tween the elderly with normal memory and the patients with
probable AD. In the second experiment, subjects with iso-
lated memory decline were dichotomized into two subgroups
based on degree of entorhinal activation—subjects with en-
torhinal activation that was 2 SD less than the normal el-
derly and those with entorhinal activation that did not differ
from the normal elderly. One-factor (group) multivariate
analyses of variance were then performed to determine
whether these subgroups differed from normal elderly in
degree of activation in the hippocampus proper and the
subiculum.
Results
All subjects in the normal elderly group had significant
hippocampal activation, determined by x2 analyses
showing a significant (p , 0.0005) number of acti-
vated pixels compared with the number expected by
chance at an a of 0.05. A limited example is shown in
Figure 1. The AD group was found to be younger
(mean, 70.5 years; range, 65–76 years) than the normal
memory group (mean, 80 years; range, 73–85 years).
Because increased age is associated with hippocampal
atrophy, this may bias the results against finding acti-
vation differences. Nevertheless, the AD subjects were
found to have significantly diminished activation com-
pared with normal elderly in all hippocampal regions
(entorhinal cortex: F 5 22.97, p , 0.005; hippocam-
pal proper: F 5 26.72, p , 0.001; subiculum: F 5
11.48, p , 0.01). A limited example of a subject with
AD is shown in Figure 2. Group data across the three
hippocampal regions are shown in Figure 3, which
demonstrates no overlap in entorhinal activation be-
tween the normal and the AD groups.
As a group, the mean age of the 12 subjects with
isolated memory decline (78.3 years; range, 72–87
years) was not different from the mean age in subjects
with normal memory (80 years; range, 73–85 years).
Results from the second experiment revealed that, of
the 12 subjects with memory decline, 4 had dimin-
ished entorhinal activation (2EC subgroup) and 8 had
normal entorhinal activation (1EC subgroup). Limited
examples from each subgroup are shown in Figure 2,
and group data are shown in Figure 3. Further analysis
revealed that the 2EC subgroup had diminished acti-
vation in the hippocampus proper (F 5 26.72, p ,
0.005) and the subiculum (F 5 12.31, p , 0.01) com-
pared with normal elderly; and that the 1EC subgroup
had diminished activation restricted to the subiculum
(F 5 8.99, p , 0.01).
Discussion
In this study we present an fMRI protocol developed
to perform regional analysis of the hippocampal forma-
tion. In the first experiment, we established the re-
gional activation pattern in patients with AD. By the
time AD results in dementia, pathology involves all
hippocampal regions.21 Finding that AD subjects had
diminished activation in all hippocampal regions com-
pared with normal elderly is, therefore, the expected
finding and acts to validate the fMRI protocol used. In
the second experiment, we evaluated 12 elderly subjects
with a similar behavioral profile, that of declarative
memory decline but no dementia. Based on the pri-
macy of entorhinal pathology in AD,10,21,26 we pre-
dicted that these subjects could be dichotomized on
the basis of entorhinal function. Indeed, we found that
4 of these subjects had entorhinal dysfunction (the
2EC subgroup) whereas 8 of them had normal ento-
rhinal function (the 1EC subgroup). Among the 2EC
subgroup, further analysis revealed diminished activa-
tion in all hippocampal regions, and their regional ac-
tivation pattern was indistinguishable from the pattern
generated in patients with AD. Because the entorhinal
cortex is the first subregion of the hippocampal circuit,
a lesion here would be expected to result in diminished
activity throughout the circuit. Alternatively, it is pos-
sible that the the presumptive AD pathology in these
subjects had already progressed beyond the entorhinal
cortex to include other hippocampal regions. We are
currently evaluating extrahippocampal sites in the tem-
poral and parietal cortices and predict that only AD
patients will manifest diminished activation in these
neocortical sites. We are also evaluating the apoli-
poprotein E genotype of all subjects with memory de-
cline, to determine whether the 2EC subgroup has an
increased frequency of the apolipoprotein E 4 allele.
The subgroup of subjects with hippocampal-based
memory decline and preserved entorhinal function are
unlikely to have early AD. Nevertheless, these subjects
were found to have hippocampal dysfunction, but di-
minished activation was restricted to the subiculum.
Selective subicular dysfunction may result from physi-
ological or structural lesion to this region, which would
fit well with recent postmortem findings from brains
without AD, showing age-dependent subicular cell
loss.11,12 Alternatively, diminished activation in the
subiculum may arise from lesions upstream in the hip-
pocampal circuit in the CA regions, where animal
studies have demonstrated age-related physiological
deficits.9,19
Prospective follow-up will validate whether those
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subjects with memory decline and entorhinal dysfunc-
tion are more likely to progress to AD dementia com-
pared with those subjects with normal entorhinal func-
tion. If so, the fMRI protocol presented in this study
will benefit both AD research and the study of
non-AD memory decline. The rationale behind current
interventions of AD is halting disease progression, and
therefore, a major goal is early detection. The fMRI
protocol may be developed as a tool for detecting AD
at its earliest stages, where it presents with mild mem-
ory decline. The rigorous study of non-AD age-related
memory decline has been hindered, and remains a con-
Fig 2. Representative examples from each of the
experimental groups. The two most posterior sec-
tions acquired from the six section volumes are
shown. Only pixels that overlie the hippocampal
formation were selected for analysis. Those pixels
whose signal intensity significantly increased in
association with the presentation of faces are
color-coded in red. (A) An 83-year-old man with
normal memory. (B) A 81-year-old woman with
memory decline and normal enterorhinal activa-
tion. (C) A 78-year-old man with memory de-
cline and sparse entorhinal activation. (D) A
76-year-old woman with probable Alzheimer’s
disease.
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troversial entity, in large part because of the inability to
select out those subjects with early AD. The fMRI pro-
tocol may also be used to isolate a group of elderly
individuals with non-AD memory decline. This will al-
low better characterization of its clinical presentation
and course, and the testing of candidate processes as
underlying etiologies.
In summary, the results of this study show that age-
related memory decline is associated with hippocampal
dysfunction. More important, regional analysis of the
hippocampal formation provided direct evidence that
age-related memory decline is not caused by a singular
process. Showing that AD subjects and a subset of sub-
jects with memory decline have an indistinguishable
pattern of regional dysfunction supports the likelihood
that AD is one cause of memory decline. A second pat-
tern of regional dysfunction, however, found in a dif-
ferent subset of subjects with memory decline, is diffi-
cult to reconcile with the established distribution of
AD pathology. Non-AD processes that selectively tar-
get the hippocampal proper and the subiculum can
more easily account for this regional pattern. Both
early AD and non-AD processes, therefore, are im-
plicated as underlying causes of age-related memory
decline.
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